Crescita Therapeutics, Inc. - ROE
CRRTF
Price:
$0.5587
Market Cap:
$14.71M
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermat...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2016-04-11
Stock Exchange
OTC
Ticker
CRRTF
PE Ratio
[-42.49]
ROE
[-2.07%]
Current Ratio
[2.80]
Dividend Yield
[0%]
Enterprise Value
[8.50M]
Dividend History
The ROE as of August 2026 (TTM) for Crescita Therapeutics, Inc. (CRRTF) is -2.07%
According to Crescita Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.07%. This represents a change of 188.98% compared to the average of -0.72% of the last 4 quarters.
Crescita Therapeutics, Inc. (CRRTF) Historical ROE (quarterly & annually)
How has CRRTF ROE performed in the past?
The mean historical ROE of Crescita Therapeutics, Inc. over the last ten years is -15.15%. The current -2.07% ROE has changed -86.34% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's ROE was at its highest in in the September 2020 quarter at 19.32%. The ROE was at its lowest in in the December 2017 quarter at -63.00%.
Average
-15.15%
Median
-2.99%
Minimum
-87.46%
Maximum
12.61%
Crescita Therapeutics, Inc. (CRRTF) ROE by Quarter and Year
Discovering the peaks and valleys of Crescita Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.65%
Maximum Annual ROE = 12.61%
Minimum Annual Increase = -3174.80%
Minimum Annual ROE = -87.46%
| Year | ROE | Change |
|---|---|---|
| 2025 | -0.59% | -96.60% |
| 2024 | -17.37% | 64.65% |
| 2023 | -10.55% | -358.23% |
| 2022 | 4.09% | -175.90% |
| 2021 | -5.38% | -3174.80% |
| 2020 | 0.18% | -98.01% |
| 2019 | 8.79% | -30.29% |
| 2018 | 12.61% | -114.41% |
| 2017 | -87.46% | 56.85% |
| 2016 | -55.76% | -112.15% |
Crescita Therapeutics, Inc. (CRRTF) Average ROE
How has CRRTF ROE performed in the past?
The current ROE of Crescita Therapeutics, Inc. (CRRTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.51%
5-year avg
-5.96%
10-year avg
-15.15%
Crescita Therapeutics, Inc. (CRRTF) ROE vs. Peers
How is CRRTF’s ROE compared to its peers?
Crescita Therapeutics, Inc.’s ROE is less than Ayurcann Holdings Corp. (173.94%), greater than Delivra Health Brands Inc. (-26.42%), greater than Ayr Wellness Inc. (-74.75%), greater than Christina Lake Cannabis Corp. (-31.36%), greater than CV Sciences, Inc. (-94.61%), greater than Bright Green Corporation (-116.46%), greater than CanaFarma Hemp Products Corp. (-783.66%), greater than Healthy Extracts Inc. (-3.76%), less than Univec, Inc. (6.94%), less than Tristar Wellness Solutions Inc. (0.25%),
| Company | ROE | Market cap |
|---|---|---|
| 173.94% | $58.41K | |
| -26.42% | $2.21M | |
| -74.75% | $432.06K | |
| -31.36% | $4.86M | |
| -94.61% | $4.94M | |
| -116.46% | $7.26M | |
| -783.66% | $19.56K | |
| -3.76% | $4.20M | |
| 6.94% | $7.82M | |
| 0.25% | $56.00K |
Build a custom stock screener for Crescita Therapeutics, Inc. (CRRTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Crescita Therapeutics, Inc. (CRRTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Crescita Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Crescita Therapeutics, Inc.'s ROE?
How is the ROE calculated for Crescita Therapeutics, Inc. (CRRTF)?
What is the highest ROE for Crescita Therapeutics, Inc. (CRRTF)?
What is the 3-year average ROE for Crescita Therapeutics, Inc. (CRRTF)?
What is the 5-year average ROE for Crescita Therapeutics, Inc. (CRRTF)?
How does the current ROE for Crescita Therapeutics, Inc. (CRRTF) compare to its historical average?